BriaCell Therapeutics Corp. (TSX:BCT)
Canada · Delayed Price · Currency is CAD 6.17
+0.34 (5.83%)
Jan 22, 2026, 3:59 PM EST
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of CAD 10.98 million as of January 22, 2026. Its market cap has decreased by -63.46% in one year.
Market Cap
10.98M
Enterprise Value
-4.16M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.17
Market Cap Chart
Since December 3, 2014, BriaCell Therapeutics's market cap has decreased from 24.42M to 10.98M, a decrease of -55.02%. That is a compound annual growth rate of -6.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 10.98M | -40.51% |
| Dec 31, 2025 | 18.46M | -48.44% |
| Dec 31, 2024 | 35.81M | -71.28% |
| Dec 29, 2023 | 124.66M | 36.15% |
| Dec 30, 2022 | 91.56M | -44.85% |
| Dec 31, 2021 | 166.03M | 3,496.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lobe Sciences | 14.82M |
| Innovotech | 13.00M |
| Britannia Life Sciences | 12.98M |
| PreveCeutical Medical | 11.96M |
| Cytophage Technologies | 11.84M |
| Pharmala Biotech Holdings | 10.89M |
| BioVaxys Technology | 10.14M |
| COSCIENS Biopharma | 9.49M |